CA1212943A - Methode de preparation de 1,8-dihydroxy-10-acyl-9- anthrones, principalement pour le traitement du psoriasis - Google Patents

Methode de preparation de 1,8-dihydroxy-10-acyl-9- anthrones, principalement pour le traitement du psoriasis

Info

Publication number
CA1212943A
CA1212943A CA000454593A CA454593A CA1212943A CA 1212943 A CA1212943 A CA 1212943A CA 000454593 A CA000454593 A CA 000454593A CA 454593 A CA454593 A CA 454593A CA 1212943 A CA1212943 A CA 1212943A
Authority
CA
Canada
Prior art keywords
dihydroxy
anthrone
acyl
formula
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000454593A
Other languages
English (en)
Inventor
Pekka J. Kairisalo
Aino K. Pippuri
Erkki J. Honkanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Application granted granted Critical
Publication of CA1212943A publication Critical patent/CA1212943A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
CA000454593A 1983-05-18 1984-05-17 Methode de preparation de 1,8-dihydroxy-10-acyl-9- anthrones, principalement pour le traitement du psoriasis Expired CA1212943A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI831739A FI66585C (fi) 1983-05-18 1983-05-18 Foerfarande foer framstaellning av saerskilt vid behandling avsoriasis anvaendbara 1,8-dihydroxi-10-acyl-9-antroner
FI831739 1983-05-18

Publications (1)

Publication Number Publication Date
CA1212943A true CA1212943A (fr) 1986-10-21

Family

ID=8517222

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000454593A Expired CA1212943A (fr) 1983-05-18 1984-05-17 Methode de preparation de 1,8-dihydroxy-10-acyl-9- anthrones, principalement pour le traitement du psoriasis

Country Status (31)

Country Link
JP (1) JPS59212443A (fr)
KR (1) KR840009059A (fr)
AU (1) AU560079B2 (fr)
BE (1) BE899334A (fr)
CA (1) CA1212943A (fr)
CH (1) CH659464A5 (fr)
CS (1) CS256379B2 (fr)
DD (1) DD223702A5 (fr)
DE (1) DE3418382A1 (fr)
DK (1) DK154207C (fr)
ES (1) ES8505167A1 (fr)
FI (1) FI66585C (fr)
FR (1) FR2546162B1 (fr)
GB (1) GB2140007B (fr)
GR (1) GR79971B (fr)
HU (1) HUT36076A (fr)
IL (1) IL71446A (fr)
IN (1) IN156115B (fr)
IS (1) IS2902A7 (fr)
IT (1) IT1173473B (fr)
LU (1) LU85292A1 (fr)
NL (1) NL8401074A (fr)
NO (1) NO157099C (fr)
NZ (1) NZ207592A (fr)
PH (1) PH20038A (fr)
PL (1) PL141866B1 (fr)
PT (1) PT78603B (fr)
SE (1) SE453827B (fr)
SU (1) SU1240351A3 (fr)
YU (1) YU81784A (fr)
ZA (1) ZA842223B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2591222B1 (fr) * 1985-12-11 1988-07-22 Cird Mono, di et tri-esters de dihydroxy-1,8 phenyl-10 anthrone-9 ou anthranol-9, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US4843097A (en) * 1984-06-13 1989-06-27 Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics
FR2566772B1 (fr) * 1984-06-29 1986-11-14 Cird Diacyloxy-1,8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2580631B1 (fr) * 1985-04-17 1987-05-29 Cird Hydroxy-1 acyloxy-8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
AU660718B2 (en) * 1991-10-04 1995-07-06 Fisher & Paykel Healthcare Limited Improvements in or relating to humidifiers
DE4231636A1 (de) * 1992-09-22 1994-03-24 Beiersdorf Ag Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung
US5426197A (en) * 1993-07-19 1995-06-20 Teva Pharmaceutical Industries, Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI57743C (fi) * 1979-03-29 1980-10-10 Orion Yhtymae Oy Foerfarande foer framstaellning av nya 1,8-dihydroxi-10-acyl-9-antroner mot psoriasis

Also Published As

Publication number Publication date
IL71446A (en) 1987-01-30
GB8408666D0 (en) 1984-05-16
DK154207B (da) 1988-10-24
BE899334A (fr) 1984-07-31
AU2599884A (en) 1984-11-22
IT8420213A0 (it) 1984-03-23
DK173584D0 (da) 1984-03-30
AU560079B2 (en) 1987-03-26
JPS59212443A (ja) 1984-12-01
ZA842223B (en) 1984-11-28
NO157099B (no) 1987-10-12
YU81784A (en) 1986-10-31
SE453827B (sv) 1988-03-07
IT1173473B (it) 1987-06-24
DD223702A5 (de) 1985-06-19
ES531760A0 (es) 1985-05-16
FR2546162B1 (fr) 1987-01-30
FI66585B (fi) 1984-07-31
GB2140007B (en) 1986-04-09
LU85292A1 (fr) 1984-10-26
IL71446A0 (en) 1984-07-31
DK154207C (da) 1989-03-13
PL247724A1 (en) 1985-06-18
KR840009059A (ko) 1984-12-24
HUT36076A (en) 1985-08-28
FI66585C (fi) 1984-11-12
PH20038A (en) 1986-09-04
IN156115B (fr) 1985-05-18
CS256379B2 (en) 1988-04-15
PT78603B (en) 1986-06-26
NO157099C (no) 1988-01-20
NL8401074A (nl) 1984-12-17
CH659464A5 (de) 1987-01-30
DK173584A (da) 1984-11-19
SE8402649D0 (sv) 1984-05-16
ES8505167A1 (es) 1985-05-16
PT78603A (en) 1984-06-01
CS291184A2 (en) 1987-08-13
NO841965L (no) 1984-11-19
SE8402649L (sv) 1984-11-19
NZ207592A (en) 1986-11-12
GB2140007A (en) 1984-11-21
PL141866B1 (en) 1987-09-30
FI831739A0 (fi) 1983-05-18
SU1240351A3 (ru) 1986-06-23
GR79971B (fr) 1984-10-31
DE3418382A1 (de) 1984-11-22
FR2546162A1 (fr) 1984-11-23
IS2902A7 (is) 1984-06-07

Similar Documents

Publication Publication Date Title
CA1212943A (fr) Methode de preparation de 1,8-dihydroxy-10-acyl-9- anthrones, principalement pour le traitement du psoriasis
DE2756169C2 (de) Verfahren zur Herstellung von Perfluorcarbonsäuren oder Perfluoralkansulfonylchloriden
EP0034741B1 (fr) Procédé pour la préparation d'un bromofluorobenzène substitué et de 3-bromo-4-fluorobenzonitrile
EP0006999B1 (fr) Procédé pour préparer des dérivés de 2-chlorobenzonitrile
EP0169688B1 (fr) Procédé de préparation de dérivés d'acide cycloalcoylidèneméthylphénylacétique à action anti-inflammatoire
EP0026894A1 (fr) Procédé de préparation de l'érythro-alpha-2-pipéridyl-2,8-bis-(trifluorométhyl)-4-quinoléine-méthanol
NO149630B (no) Analogifremgangsmaate til fremstilling av anti-psoriatiske 1,8-dihydroksy-10-acyl-9-antroner
JPS61229875A (ja) 新規化合物n,n′−メチレンビス(2−アミノ−5−メルカプト−1,3,4−チアジアゾ−ル),及び同化合物の製造方法並びに同化合物を有効成分とする細菌性植物病害の予防及び治療用殺菌剤及び同病害の防除方法
US5166453A (en) Method for purification of ethylene compounds having fluorine-containing organic group
DE2524299C2 (de) Verfahren zur Herstellung von Toluoyl-1-methyl-pyrrol-2-acetonitrilen
Morgan et al. CVI.—Researches on residual affinity and co-ordination. Part VIII. Interaction of tellurium tetrachloride and β-diketones
EP0010787B1 (fr) Isomérisation de dérivés du 3-azabicyclo(3.1.0)hexane
KR910009415B1 (ko) 비스(펜옥시)아세틸 nn-디메틸 아미드의 제조방법
EP0337277A1 (fr) Dérivés de pyrrole
DE2645114A1 (de) Verfahren zur halogenierung und halogenierenden oxydation aromatischer verbindungen
DE1292664B (de) 1, 2, 3, 5, 6-Pentathiacycloheptan, Verfahren zu dessen Herstellung und Verwendung
KR920010638B1 (ko) 1,1-비스(4-클로로페닐)-2,2,2-트리클로로에탄올의 제조방법.
WATANABE The Chemical Structure of the Intermediate Metabolites of Catechin. III Synthesis of the Intermediate Metabolites (G and H)
Crumbie et al. An Alternative Method for the Preparation of Cyclic Sulfides
DE2332081C2 (de) Verfahren zur Herstellung von 5-Cycloalkyl-6-halogen-indan-1-carbonsäuren
DE2642415A1 (de) Syntheseverfahren fuer in 6-stellung substituierte 2,3-dimethoxy-5-methyl-1,4- benzochinone
GB2064522A (en) Phenylbutazone Salt
Morgan et al. LXVI.—Researches on residual affinity and coordination. Part III. Reactions of selenium and tellurium acetylacetones
KR940011130B1 (ko) 4-아미노-4'-알킬벤조페논의 제조방법
Křepelka et al. Derivatives of 4-aryl-2, 3-dihalogeno-1-naphthol

Legal Events

Date Code Title Description
MKEX Expiry